The ECG: A Vital Noninvasive Window in The Management Of Lung Disease

The ECG: A Vital Noninvasive Window in the Management of Lung Disease

Respiratory diseases such as chronic obstructive pulmonary disease (COPD), pulmonary embolism and pulmonary hypertension affect not only the lungs but also the heart through the pulmonary circulation. As a noninvasive, rapid and repeatable baseline test, the electrocardiogram (ECG) records the heart's electrical activity and indirectly reflects the load and structural changes of the right heart. It is therefore widely recognized as an important adjunct throughout the management of pulmonary disease.

Its clinical value lies in three main areas. First, it suggests pulmonary hypertension and cor pulmonale. Chronic lung disease can raise pulmonary vascular resistance, causing dilation and hypertrophy of the right atrium and ventricle. The ECG may then show "P pulmonale" (tall, peaked Pwaves in leads II, III and aVF), rightward deviation of the QRS axis, and poor R-wave progression across the precordial leads-clues that the right heart is affected. Second, it aids recognition of acute pulmonary embolism. Obstruction of the pulmonary arteries can produce acute right-ventricular overload, with classic findings such as the S1Q3T3 pattern, right bundle branch block and T-wave inversion in leads V1–V3, while sinus tachycardia is the most common abnormality. The ECG also helps rapidly distinguish acute myocardial infarction-which can present similarly-and supports risk stratification. Third, it monitors disease progression and treatment response. Because hyperexpanded lungs sit between the heart and the electrodes, COPD patients often show low voltage and are prone to arrhythmias such as multifocal atrial tachycardia and atrial fibrillation; serial ECGs can track right-heart strain and rhythm changes to assess response to therapy.

Importantly, the ECG has limited sensitivity: a normal tracing does not rule out conditions such as pulmonary embolism, and diagnosis still requires integration with echocardiography, CT pulmonary angiography and blood-gas analysis. Through standardized acquisition, serial comparison and comprehensive interpretation, this fundamental test can deliver real value in the early screening, assessment and long-term follow-up of respiratory disease.